ONESOURCE1,548.10

Onesource Specialty Pharma Ltd.

· Pharma & Health
₹ CrorePeersSTARDIVISLABGLANDPFIZERPOLYMEDRAINBOWKIMSJUBLPHARMAMcap ₹17,744 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation273.9279.1
+ Impairment Loss / (Reversal)0.10.0
+ Finance Costs166.3122.2
+ Interest Income15.8-11.7
+ Fair Value (Gains) / Losses-2.70.0
+ Share-based Payments4.32.7
+ Unrealised FX (Gain) / Loss0.0-19.0
+ Other Non-cash Items0.012.6
+ Other Reconciling Items0.7-0.1
Changes in Working Capital
+ Inventories44.0-280.9
+ Trade Receivables — Current-257.1-189.6
+ Other Financial Assets — Current0.013.0
+ Other Current Assets-74.90.0
+ Trade Payables — Current-117.6208.9
+ Other Current Liabilities-14.2-28.0
Cash from Operating Activities
Profit Before Tax (per I/S)-67.1-92.0-67.3
+ Total Adjustments (incl. Working Capital)38.5109.2
Cash from Operations (pre-tax)-28.517.3
+ Income Taxes Paid-7.08.7
Cash from Operating Activities-21.58.5
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)0.0569.1
+ Disp of Fixed Assets-123.70.0
+ Interest Received — Investing13.20.0
+ Other Inflows / (Outflows) — Investing-90.674.1
Cash from Investing Activities-201.1-495.0
Cash from Financing Activities
+ Proceeds from Issue of Shares875.55.7
+ Proceeds from Borrowings345.1703.8
+ Repayment of Borrowings-631.0207.4
+ Payment of Lease Liabilities0.023.6
+ Interest Paid-156.5119.1
+ Other Inflows / (Outflows) — Financing-21.00.0
Cash from Financing Activities1,987.2359.4
Net Changes in Cash (pre-FX)1,764.6-127.0
Net Changes in Cash1,764.6-127.0
Closing Cash165.4
Reference Items
EBITDA466.5304.2339.1
EBITDA Margin %32.2921.4021.97
Free Cash Flow (CFO − Capex)-21.5-560.5-560.5
Free Cash Flow to Equity-174.9
Free Cash Flow per Basic Share-1.88-48.90-48.90
Cash Flow to Net Income1.20-0.12
Cash Paid for Taxes-7.08.7
Cash Paid for Interest-156.5119.1
As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.